Answers are grounded in this paper and cite their sources.
Sir, A 43-year-old man was diagnosed with HIV infection [cluster of differentiation (CD4) count: 237/µL; viral load: 45 291 copies/ml] in March 2017 and started on highly active anti-retroviral therapy (HAART) including cobicistat, elvitegravir, emtricitabine and tenofovir at the beginning of May 2017. He had no significant medical history. He was a native of Central African Republic and had moved to France 1 year ago. About 1 month after HAART initiation, the patient reported moderate arthralgia and evanescent non-pruriginous rash, followed by high spiking fever (>39°C) and rigors. Over a few days, he developed painful large-joint polyarthritis involving knees, wrists and shoulders. The patient was bedridden and started on morphine. Examination revealed pyrexia and effusions in all his large joints. Biological results showed a marked acute phase response (CRP: 427 mg/L; neutrophils: 11 400/µL) associated with increased serum aminotransferase levels (>5 times the upper limit). HIV load was undetectable and CD4 count was 367/µL. Extensive investigations for infection were negative, including blood, stool and urine cultures, serology (Brucella, Rickettsia, Bartonella, Chlamydia, Mycoplasma, Treponema, Strongyloides spp.), and PCR (Chlamydia, Neisseria gonorrhoeae, CMV, EBV, HHV8, parvovirus B19). A tuberculosis test (IFN-γ release assay) was negative. Knee synovial fluid analysis revealed inflammatory liquid (nucleated cells: 14 940/µL; neutrophils: 13 740/µL) without any evidence for infection (fluid culture, 16S ribosomal RNA amplification) or crystals. Furthermore, RF, ACPA, ANA and ANCA were absent. However, there was a marked increase in serum ferritin level (96 876 µg/L), while glycosylated ferritin was low (10%). The diagnosis of haemophagocytic lymphohistiocytosis was ruled out because of elevated fibrinogen, absence of cytopenia, hypertriglyceridaemia or haemophagocytosis on bone marrow aspiration. The patient received empirical antimicrobial treatment (cefazolin, gentamycin) without any efficacy.
No takes yet. Share an insight, caveat, or question.
Bottlaender et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: